FDA approves Kisunla for early Alzheimer’s treatment By Investing.com
INDIANAPOLIS - The U.S. Food and Drug Administration (FDA) has approved Eli Lilly and Company (NYSE:)'s Kisunla™ (donanemab-azbt) for the ...
INDIANAPOLIS - The U.S. Food and Drug Administration (FDA) has approved Eli Lilly and Company (NYSE:)'s Kisunla™ (donanemab-azbt) for the ...
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.